Trial intelligence / Profile preview

Pregabalin versus gabapentin crossover trial in sciatica

ACTRN12613000559718Phase 3Terminated

Sponsor
Townsville University Hospital
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of pregabalin and gabapentin in Sciatica, sponsored by Townsville University Hospital. Primary endpoint: Sciatic pain reduction. Started Mar 2016; status: terminated.

02

Drugs

pregabalingabapentin
03

Conditions

Sciatica

Beyond the preview

Go deeper on ACTRN12613000559718.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613000559718.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call